Breaking News
Investing Pro 0
New Year’s SALE: Up to 40% OFF InvestingPro+ CLAIM OFFER

COVID-19 kills more than 4,000 Indians amid clamour for vaccines

Coronavirus May 13, 2021 09:03AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
5/5 © Reuters. Healthcare workers transfer the body of a person who died from the coronavirus disease (COVID-19), inside a hospital premises in Kolkata, India, May 12, 2021. REUTERS/Rupak De Chowdhuri 2/5
 
PFE
-0.55%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AZN
+0.47%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

By Tanvi Mehta and Anuron Kumar Mitra

NEW DELHI (Reuters) - India recorded more than 4,000 COVID-19 deaths for a second straight day on Thursday as infections stayed below 400,000, and extended the interval between doses of the AstraZeneca (NASDAQ:AZN) vaccine to up to 16 weeks amid a dire shortage of shots in the country.

Experts remain unsure when numbers will peak and concern is growing about the transmissibility of the variant that is driving infections in India and spreading worldwide.

Bhramar Mukherjee, a professor of epidemiology at the University of Michigan, said most models had predicted a peak this week and that the country could be seeing signs of that trend.

Still, the number of new cases each day is large enough to overwhelm hospitals, she said on Twitter. "The key word is cautious optimism."

The situation is particularly bad in rural areas of Uttar Pradesh, India's most populous state with a population of over 240 million. Television pictures have shown families weeping over the dead in rural hospitals or camping in wards to tend the sick.

Bodies have washed up in the Ganges, the river that flows through the state, as crematoriums are overwhelmed and wood for funeral pyres is in short supply.

"Official statistics give you no idea of the devastating pandemic that is raging through rural UP," wrote well-known activist and opposition politician Yogendra Yadav in The Print.

"Widespread ignorance, lack of nearby or adequate testing facilities, official and unofficial cap on testing and inordinate delays in test reports have meant that in village after village, virtually no one has been tested, while scores of people complain of a ‘strange fever’".

According to health ministry data, India had 362,727 new COVID-19 infections over the last 24 hours while deaths climbed by 4,120.

CLAMOUR FOR VACCINES

The second wave of infections, which erupted in February, has been accompanied by a slowdown in vaccinations, although Prime Minister Narendra Modi announced that vaccinations would be open to all adults from May 1.

Although it is the world's largest vaccine producer, India has run low on stocks in the face of the huge demand. As of Thursday, it had fully vaccinated just over 38.2 million people, or about 2.8% of a population of about 1.35 billion, government data shows.

The health ministry on Thursday accepted a recommendation by a government panel to extend the gap between the first and second dose of the AstraZeneca vaccine made at the Serum Institute of India to 12-16 weeks, from 6-8 weeks currently.

The recommendation, aided in part by evidence from the UK, comes as India faces extreme shortage of vaccines.

There were no changes in the interval for the domestically developed Covaxin, the other shot being used in the country.

The government of most populous Uttar Pradesh said it will spend up to $1.36 billion to buy COVID-19 shots and held early talks this week with companies such as Pfizer (NYSE:PFE) and the local distributor of Russia's Sputnik.

More than 2 billion doses of coronavirus vaccines will likely be available in India between August to December this year, top government advisor V.K.Paul told reporters amid criticism that the government had mishandled the vaccine plan.

Those doses would include 750 million of AstraZeneca's vaccine, as well as 550 million doses of Covaxin, made by Bharat Biotech.

(Graphic: India vaccine availability Aug-Dec, https://graphics.reuters.com/HEALTH-CORONAVIRUS/dgkvlobnopb/chart.png)

"We are going through a phase of finite supply. The entire world is going through this. It takes time to come out of this phase," Paul said. Some consignments of the Sputnik vaccine had also arrived in the country and he was hopeful they would be available from next week, he said.

Two states - Karnataka, which includes tech hub Bengaluru, and Maharashtra, which includes Mumbai - have announced they will temporarily suspend vaccination for people aged 18-44 years as they prioritize those over 45 who need their second dose.

Maharashtra also announced that curbs on movement would be extended until the end of the month in a bid to break the chain of infections. Mostly rural Bihar in the east extended curbs until May 25.

Modi has left it to state governments to impose such curbs.

The head of the Indian Council of Medical Research, the main health agency responding to the pandemic, has told Reuters that areas with high infections had to be locked down for 6-8 weeks.

COVID-19 kills more than 4,000 Indians amid clamour for vaccines
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email